Document is current
Any future updates will be listed below
-
Authors
Griffin, Julia N.
Danowski, Morgan E.
Gerety, Haley L.
Lafferty, Katherine
Clayman, Marla L.
Antwi, Ashley A.
Bertero, Mercedes G.
Brunette, Charles A.
Gillespie, Chris
Guentert, Louise
Lennon, Niall J.
Martin, Julian
Patel, Lauren S.
Vassy, Jason L.
-
Funding
Funding for this research was provided by:
U.S. Department of Veterans Affairs
- License Information
-
More Information
Article History
Received: 5 April 2026
Accepted: 12 June 2026
First Online: 30 July 2026
Declarations
Ethics approval and consent to participate: The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) and this qualitative interview substudy were approved by the Department of Veterans Affairs Central Institutional Review Board (Protocol #23–39; amendment #E23-57). All participants provided informed consent to participate in the study. This study adhered to the Declaration of Helsinki.
Consent for publication: Not applicable.
Competing interests: N.J.L. is a scientific advisory board member for FYR Diagnostics, Everygene, and AGRF Ltd. All other authors declare that they have no competing interests relevant to the presented work.
